SBM Prostate Cancer (PSA) Screening Test is a rapid test for the qualitative detection of Prostate Specific Antigen (PSA) in human fingerstick blood. A PSA level of 4 to 10ng/ml is considered to be in the “grey-zone” and levels above 10ng/ml are highly indicative of cancer.
Patients with PSA values between 4-10ng/ml should consult their Doctor for further evaluation.
The SBM Prostate test is calibrated to record levels from 4ng/ml and above.